ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,251Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 1802

$556K Total Retail Price of All Prescriptions

Rank: 67 out of 1802

376 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 376 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

26% of this provider’s 376 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,150 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
FUROSEMIDE 460 429 1 5
SIMVASTATIN 411 310 2 1
DONEPEZIL HCL 399 386 3 26
LISINOPRIL 393 336 4 3
LEVOTHYROXINE SODIUM 375 321 5 2
OMEPRAZOLE 353 285 6 4
HYDROCODONE-ACETAMINOPHEN 335 261 S3 7 10
NAMENDA 269 269 8 34
METOPROLOL TARTRATE 268 239 9 9
METFORMIN HCL 235 173 10 11
GABAPENTIN 213 143 11 16
CITALOPRAM HBR 197 126 12 17
WARFARIN SODIUM 191 154 13 7
MIRTAZAPINE 177 176 14 38
DIVALPROEX SODIUM 177 173 14 74
POTASSIUM CHLORIDE 161 145 16 15
AMLODIPINE BESYLATE 157 120 17 6
METOPROLOL SUCCINATE 151 130 18 13
GLIMEPIRIDE 151 106 18 42
HYDROCHLOROTHIAZIDE 133 104 20 8
CARVEDILOL 125 108 21 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 120 98 22 23
ADVAIR DISKUS 112 106 23 32
POLYETHYLENE GLYCOL 3350 106 105 24 29
CLOPIDOGREL 104 97 25 48
ATORVASTATIN CALCIUM 95 68 26 14
DIGOXIN 92 92 27 45
PLAVIX 90 87 28 81
PANTOPRAZOLE SODIUM 86 75 29 44
NAPROXEN 86 28 29 94
ISOSORBIDE MONONITRATE ER 84 76 31 66
FAMOTIDINE 83 72 32 84
TRAZODONE HCL 81 77 33 39
ALLOPURINOL 81 70 33 24
OXYCODONE-ACETAMINOPHEN 81 38 S2 33 67
SERTRALINE HCL 80 51 36 20
LOVASTATIN 75 68 37 25
PROAIR HFA 75 38 37 58
RANITIDINE HCL 74 41 39 30
TRAMADOL HCL 74 61 39 22
LOSARTAN POTASSIUM 72 72 41 18
ATENOLOL 71 71 42 12
ALENDRONATE SODIUM 70 70 43 21
LOSARTAN-HYDROCHLOROTHIAZIDE 68 35 44 52
LIDODERM 67 65 45 92
LANTUS 66 50 46 47
ZOLPIDEM TARTRATE 66 52 46 27
PRAVASTATIN SODIUM 62 49 48 19
COMBIVENT 62 50 48 108
HYDRALAZINE HCL 62 62 48 119
OLANZAPINE 61 50 51 112
OXYCODONE HCL-ACETAMINOPHEN 60 0 S2 52 96
VESICARE 57 57 53 150
GALANTAMINE HBR 56 56 54 206
FLUTICASONE PROPIONATE 54 25 55 37
NEXIUM 50 29 56 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.